This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Jim Cramer's Stop Trading: Colgate, Clorox to Benefit in Venezuela

Stocks in this article: CLAVPCLXPGKMB

NEW YORK (TheStreet) -- "No one's picking up on this and it's surprising to me," TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, said in regards to Venezuela's plan to relax its foreign exchange system. 

On CNBC's "Cramer's Stop Trading" segment, he pointed out how many retailers operate in the country. Colgate-Palmolive (CL) has 5% of its sales coming from Venezuela. Avon Products (AVP) has 5%, Clorox (CLX) has 3%, Procter & Gamble (PG) has 2% and Kimberly Clark (KMB) also has 2%. 

And as these companies -- as well as many others -- have continued to warn investors of the negative effects that Venezuelan currency swings are having on their business, this reform will actually be good for them. 

This is "very significant" for these companies, Cramer said, as investors have grown tired of hearing the negative news. 

He concluded that each one of the stocks he listed are ones that investors can continue to own, with the exception of Avon, which he did not like for other reasons.

-- Written by Bret Kenwell in Petoskey, Mich.

Fusion-io Soars Following SanDisk Buyout

5 Worst Strategies for Paying Off Your Student Loans

Analyst Goes to Sweden, Returns Home Predicting Vertex CF Drug Failure

Adobe's Creative Solutions Will Catapult Shares to the Clouds

At the time of publication, Cramer's Action Alerts PLUS had no position in companies mentioned.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,614.81 +215.14 1.31%
S&P 500 1,941.28 +37.27 1.96%
NASDAQ 4,419.4780 +103.4040 2.40%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs